Insider · CIK 0001527197

Bahrt Kenneth

Reports to the SEC for 2 companies · EAST BRUNSWICK, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001527197

Forms 4 and 5

Insider transactions

31 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-02-19	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+600K sh	—	—	600,000
2018-10-22	OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+450K sh	—	—	450,000
2018-06-25	OTLKOutlook Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−7,700 sh	$0.85	−$6,507.27	47,120
2017-12-22	OTLKOutlook Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	+26.2K sh	$1.13	+$29.6K	54,820
2016-12-21	OTLKOutlook Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+50K sh	—	—	80,985
2016-05-13	OTLKOutlook Therapeutics, Inc.P Purchase	Chief Medical Officer	PPurchase	+2,000 sh	—	—	2,000
2016-05-13	OTLKOutlook Therapeutics, Inc. · Series B Warrants (right to buy)P Purchase	Chief Medical Officer	PPurchase	+1,000 sh	—	—	1,000
2016-05-13	OTLKOutlook Therapeutics, Inc. · Series A Warrants (right to buy)P Purchase	Chief Medical Officer	PPurchase	+1,000 sh	—	—	1,000
2013-10-16	SAVIENT PHARMACEUTICALS INCS Sale	SVP, Chief Medical Officer	SSale	−500 sh	$0.07	−$36.1	100,000
2013-10-16	SAVIENT PHARMACEUTICALS INCS Sale	SVP, Chief Medical Officer	SSale	−2,400 sh	$0.07	−$176.4	100,500
2013-10-16	SAVIENT PHARMACEUTICALS INCS Sale	SVP, Chief Medical Officer	SSale	−1,600 sh	$0.07	−$116	106,400
2013-10-16	SAVIENT PHARMACEUTICALS INCS Sale	SVP, Chief Medical Officer	SSale	−3,500 sh	$0.07	−$260.75	102,900
2013-10-15	SAVIENT PHARMACEUTICALS INCS Sale	SVP, Chief Medical Officer	SSale	−3,911 sh	$0.08	−$321.875	108,000
2013-10-15	SAVIENT PHARMACEUTICALS INCS Sale	SVP, Chief Medical Officer	SSale	−661 sh	$0.08	−$53.805	111,911
2013-10-15	SAVIENT PHARMACEUTICALS INCS Sale	SVP, Chief Medical Officer	SSale	−65.6K sh	$0.08	−$5,336.451	112,572
2013-04-30	SAVIENT PHARMACEUTICALS INCS Sale	SVP, Chief Medical Officer	SSale	−1,250 sh	$0.74	−$925	178,211
2013-03-05	SAVIENT PHARMACEUTICALS INCOption to Purchase Common StockA Award	SVP, Chief Medical Officer	AAward	+50K sh	—	—	50,000
2013-03-05	SAVIENT PHARMACEUTICALS INCOption to Purchase Common StockA Award	SVP, Chief Medical Officer	AAward	+90K sh	—	—	90,000
2013-03-05	SAVIENT PHARMACEUTICALS INCOption to Purchase Common StockA Award	SVP, Chief Medical Officer	AAward	+110K sh	—	—	110,000
2013-02-04	SAVIENT PHARMACEUTICALS INCS Sale	SVP, Chief Medical Officer	SSale	−7,300 sh	$1.01	−$7,373	193,450
2013-02-04	SAVIENT PHARMACEUTICALS INCS Sale	SVP, Chief Medical Officer	SSale	−21.7K sh	$1.04	−$22.6K	171,750
2013-01-31	SAVIENT PHARMACEUTICALS INCS Sale	SVP, Chief Medical Officer	SSale	−1,300 sh	$1.03	−$1,339	200,750
2012-10-31	SAVIENT PHARMACEUTICALS INCS Sale	SVP, Chief Medical Officer	SSale	−1,000 sh	$1.45	−$1,450	202,050
2012-08-01	SAVIENT PHARMACEUTICALS INCS Sale	SVP, Chief Medical Officer	SSale	−4,950 sh	$0.62	−$3,069	203,050
2012-02-01	SAVIENT PHARMACEUTICALS INCA Award	SVP, Chief Medical Officer	AAward	+150K sh	$2.26	+$339K	208,000
2012-02-01	SAVIENT PHARMACEUTICALS INCOption to PurchaseA Award	SVP, Chief Medical Officer	AAward	+100K sh	$2.26	+$226K	100,000
2011-11-16	SAVIENT PHARMACEUTICALS INCP Purchase	SVP, Chief Medical Officer	PPurchase	+5,000 sh	$2.59	+$12.9K	58,000
2011-09-14	SAVIENT PHARMACEUTICALS INCP Purchase	SVP, Chief Medical Officer	PPurchase	+500 sh	$3.97	+$1,982.75	53,000
2011-09-14	SAVIENT PHARMACEUTICALS INCP Purchase	SVP, Chief Medical Officer	PPurchase	+2,500 sh	$3.95	+$9,871.25	52,500
2011-07-31	SAVIENT PHARMACEUTICALS INCOption to Purchase Common Stock, $.01 par valueA Award	SVP, Chief Medical Officer	AAward	−150K sh	$7.00	−$1.05M	150,000
2011-07-31	SAVIENT PHARMACEUTICALS INCA Award	SVP, Chief Medical Officer	AAward	−50K sh	$7.00	−$350K	50,000

Recent filings

Accepted (ET)
Feb 194
Bahrt Kenneth0001209191-19-011377
SEC(opens sec.gov)
Oct 244
Bahrt Kenneth0001209191-18-056075
SEC(opens sec.gov)
Jun 274
Bahrt Kenneth0001209191-18-039725
SEC(opens sec.gov)
Dec 264
Bahrt Kenneth0001209191-17-067233
SEC(opens sec.gov)
Dec 224
Oncobiologics, Inc.0001209191-16-156578
SEC(opens sec.gov)
May 174
Oncobiologics, Inc.0001209191-16-121073
SEC(opens sec.gov)
Oct 174
SAVIENT PHARMACEUTICALS INC0001181431-13-054155
SEC(opens sec.gov)
May 14
Bahrt Kenneth0001181431-13-024355
SEC(opens sec.gov)
Mar 74
Bahrt Kenneth0001181431-13-015372
SEC(opens sec.gov)
Feb 64
Bahrt Kenneth0001181431-13-007059
SEC(opens sec.gov)

Companies

Address

ONE TOWER CENTER BLVD. 14TH FLOOR

EAST BRUNSWICK, NJ, 08816